{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:54:36Z","timestamp":1785610476215,"version":"3.56.0"},"reference-count":34,"publisher":"The Society for Free Radical Research Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2013]]},"DOI":"10.3164\/jcbn.12-118","type":"journal-article","created":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T13:55:19Z","timestamp":1362146119000},"page":"133-138","source":"Crossref","is-referenced-by-count":43,"title":["NMR-based metabolomics of urine in a mouse model of Alzheimer\u2019s disease: identification of oxidative stress biomarkers"],"prefix":"10.3164","volume":"52","author":[{"given":"Kiyoshi","family":"Fukuhara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Senoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiro","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alato","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumpei","family":"Niida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Takikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer\u2019s disease. Lancet 2011; 377: 1019\u20131031.","DOI":"10.1016\/S0140-6736(10)61349-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer\u2019s disease. Nature reviews Neuroscience 2007; 8: 499\u2013509.","DOI":"10.1038\/nrn2168"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer\u2019s disease: successive emergence of the clinical symptoms. Ann Neurol 2008; 64: 492\u2013498.","DOI":"10.1002\/ana.21509"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed 2005; 18: 143\u2013162.","DOI":"10.1002\/nbm.935"},{"key":"5","unstructured":"5 Serkova NJ, Spratlin JL, Eckhardt SG. NMR-based metabolomics: translational application and treatment of cancer. Curr Opin Mol Ther 2007; 9: 572\u2013585."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 De Meyer T, Sinnaeve D, Van Gasse B, et al. NMR-based characterization of metabolic alterations in hypertension using an adaptive, intelligent binning algorithm. Anal Chem 2008; 80: 3783\u20133790.","DOI":"10.1021\/ac7025964"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Fukuhara K, Ohno A, Ando Y, Yamoto T, Okuda H. A 1H NMR-based metabolomics approach for mechanistic insight into acetaminophen-induced hepatotoxicity. Drug Metab Pharmacokinet 2011; 26: 399\u2013406.","DOI":"10.2133\/dmpk.DMPK-11-RG-005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Lindon JC, Holmes E, Nicholson JK. Metabonomics in pharmaceutical R&amp;D. FEBS J 2007; 274: 1140\u20131151.","DOI":"10.1111\/j.1742-4658.2007.05673.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Maher AD, Lindon JC, Nicholson JK. <sup>1<\/sup>H NMR-based metabonomics for investigating diabetes. Future Med Chem 2009; 1: 737\u2013747.","DOI":"10.4155\/fmc.09.54"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 O\u2019Connell TM. Recent advances in metabolomics in oncology. Bioanalysis 2012; 4: 431\u2013451.","DOI":"10.4155\/bio.11.326"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Powers R. NMR metabolomics and drug discovery. Magn Reson Chem 2009; 47 (Suppl 1): S2\u2013S11.","DOI":"10.1002\/mrc.2461"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Lewis J, Dickson DW, Lin WL, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 2001; 293: 1487\u20131491.","DOI":"10.1126\/science.1058189"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Pawlak K, Domaniewski T, Mysliwiec M, Pawlak D. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease. Atherosclerosis 2009; 204: 309\u2013314.","DOI":"10.1016\/j.atherosclerosis.2008.08.014"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Martin JP Jr., Batkoff B. Homogentisic acid autoxidation and oxygen radical generation: implications for the etiology of alkaptonuric arthritis. Free Radic Biol Med 1987; 3: 241\u2013250.","DOI":"10.1016\/S0891-5849(87)80031-X"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Il\u2019yasova D, Scarbrough P, Spasojevic I. Urinary biomarkers of oxidative status. Clin Chim Acta 2012; 413: 1446\u20131453.","DOI":"10.1016\/j.cca.2012.06.012"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Zeisel SH, daCosta KA, Youssef M, Hensey S. Conversion of dietary choline to trimethylamine and dimethylamine in rats: dose-response relationship. J Nutr 1989; 119: 800\u2013804.","DOI":"10.1093\/jn\/119.5.800"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Verri M, Pastoris O, Dossena M, et al. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer\u2019s disease. Int J Immunopathol Pharmacol 2012; 25: 345\u2013353.","DOI":"10.1177\/039463201202500204"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 von Bernhardi R, Eugenin J. Alzheimer\u2019s disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. Antioxid Redox Signal 2012; 16: 974\u20131031.","DOI":"10.1089\/ars.2011.4082"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Bonda DJ, Mailankot M, Stone JG, et al. Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer\u2019s disease. Redox Rep 2010; 15: 161\u2013168.","DOI":"10.1179\/174329210X12650506623645"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Takikawa O. Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism. Biochem Biophys Res Commun 2005; 338: 12\u201319.","DOI":"10.1016\/j.bbrc.2005.09.032"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Okuda S, Nishiyama N, Saito H, Katsuki H. Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine. Proc Natl Acad Sci USA 1996; 93: 12553\u201312558.","DOI":"10.1073\/pnas.93.22.12553"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Fern\u00e1ndez-Ca\u00f1\u00f3n JM, Granadino B, Beltr\u00e1n-Valero de Bernab\u00e9 D, et al. The molecular basis of alkaptonuria. Nat Genet 1996; 14: 19\u201324.","DOI":"10.1038\/ng0996-19"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Braconi D, Bianchini C, Bernardini G, et al. Redox-proteomics of the effects of homogentisic acid in an <i>in vitro<\/i> human serum model of alkaptonuric ochronosis. J Inherit Metab Dis 2011; 34: 1163\u20131176.","DOI":"10.1007\/s10545-011-9377-6"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Serkova N, Fuller TF, Klawitter J, Freise CE, Niemann CU. H-NMR-based metabolic signatures of mild and severe ischemia\/reperfusion injury in rat kidney transplants. Kidney Int 2005; 67: 1142\u20131151.","DOI":"10.1111\/j.1523-1755.2005.00181.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Leo GC, Darrow AL. NMR-based metabolomics of urine for the atherosclerotic mouse model using apolipoprotein-E deficient mice. Magn Reson Chem 2009; 47 (Suppl 1): S20\u2013S25.","DOI":"10.1002\/mrc.2470"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Benzie IF, Chung WY, Tomlinson B. Simultaneous measurement of allantoin and urate in plasma: analytical evaluation and potential clinical application in oxidant:antioxidant balance studies. Clin Chem 1999; 45: 901\u2013904.","DOI":"10.1093\/clinchem\/45.6.901"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Moreira PI, Duarte AI, Santos MS, Rego AC, Oliveira CR. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer\u2019s disease. J Alzheimers Dis 2009; 16: 741\u2013761.","DOI":"10.3233\/JAD-2009-0972"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Honda K, Smith MA, Zhu X, et al. Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J Biol Chem 2005; 280: 20978\u201320986.","DOI":"10.1074\/jbc.M500526200"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Moreira PI, Harris PL, Zhu X, et al. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. J Alzheimers Dis 2007; 12: 195\u2013206.","DOI":"10.3233\/JAD-2007-12210"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Nunomura A, Perry G, Aliev G, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001; 60: 759\u2013767.","DOI":"10.1093\/jnen\/60.8.759"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Sultana R, Butterfield DA. Role of oxidative stress in the progression of Alzheimer\u2019s disease. J Alzheimers Dis 2010; 19: 341\u2013353.","DOI":"10.3233\/JAD-2010-1222"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Rahmadi A, Steiner N, M\u00fcnch G. Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer\u2019s disease. Clin Chem Lab Med 2011; 49: 385\u2013391.","DOI":"10.1515\/CCLM.2011.079"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Butterfield DA, Bader Lange ML, Sultana R. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer\u2019s disease. Biochim Biophys Acta 2010; 1801: 924\u2013929.","DOI":"10.1016\/j.bbalip.2010.02.005"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Gella A, Durany N. Oxidative stress in Alzheimer disease. Cell Adh Migr 2009; 3: 88\u201393.","DOI":"10.4161\/cam.3.1.7402"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T17:42:10Z","timestamp":1715017330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/52\/2\/52_12-118\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.12-118","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}